Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention

ESSENTIALS: Acquired hemophilia A is a rare bleeding disorder often accompanied by other comorbidities. We describe emicizumab use in acquired hemophilia A complicated by acute coronary syndrome. Emicizumab proved safe and effective in a patient with acquired hemophilia A. Emicizumab facilitated suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dane, Kathryn E., Lindsley, John P., Streiff, Michael B., Moliterno, Alison R., Khalid, Mian K., Shanbhag, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611359/
https://www.ncbi.nlm.nih.gov/pubmed/31294330
http://dx.doi.org/10.1002/rth2.12201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611359/
https://www.ncbi.nlm.nih.gov/pubmed/31294330
http://dx.doi.org/10.1002/rth2.12201

Ejemplares similares